Sanofi is strongly committed to improving access to care for patients with epilepsy in
developing countries. Programs are being implemented in Africa, Asia and Latin America …

Some diseases, such as epilepsy, are simply neglected in the tropics, even if they aren't
neglected tropical diseases. Epilepsy is a major source of death and disability in Africa [1] …

Akinyemi R, Yepnjio F, Njamnshi AK.(2008) Neuroscience in Africa: raising the next
generation and changing attitudes towards epilepsy: IBRO brain campaign funds Pre …

Healthcare systems in many low income countries have evolved to provide services for
acute, infections and are poorly structured for the provision of chronic, non-communicable …

Objective: To delineate a model for epilepsy care in Zambia aimed at providing most
services at the primary healthcare level, detail rationale referral patterns and care provision …

Results: From 1 June 2010 to 1 June 2011, 615 of the 816 patients studied during the pilot
project's extension to the six PCUs participated in the study. The gender ratio (M/F) was …

Nearly 80% of the 50 million people with epilepsy worldwide reside in developing countries
that are least equipped to tackle the enormous medical, social and economic challenges …

Although 80% of people with epilepsy reside in resource poor, developing countries,
epilepsy care in these regions remains limited and the majority of epilepsy patients go …

T he Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders (IGAP)
2022-2031 recognizes the gap in availability of essential medicines to treat neurological …

Conclusion This is a very useful article for any reader wanting a succinct review of the
impact of epilepsy and its treatment. It provides useful information on the differences …